tarenflurbil (Flurizan, R-flurbiprofen)

From Aaushi
Jump to navigation Jump to search

Introduction

Not FDA-approved.

Indications

Dosage

800 mg PO BID

Adverse effects

Mechanism of action

More general terms

References

  1. Jump up to: 1.0 1.1 Green RC et al. Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: A randomized controlled trial. JAMA 2009 Dec 16; 302:2557. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20009055
    Montine TJ and Larson EB. Late-life dementias: Does this unyielding global challenge require a broader view? JAMA 2009 Dec 16; 302:2593. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20009062

Database